Changchun High-Tech Industry Co. Ltd. (000661)

Overview

Changchun High-Tech Industry (Group) Co., Ltd. is a prominent entity in the Chinese biopharmaceutical sector, with a broad portfolio that encompasses the research, development, manufacture, and sales of a variety of pharmaceutical products. Since its inception in 1993, the company has established a robust presence in China’s pharmaceutical landscape, specializing in biopharmaceuticals and traditional Chinese medicines. Headquartered in Changchun, China, Changchun High-Tech extends its operations beyond pharmaceuticals to include real estate development, showcasing its diversified business model. This multifaceted approach positions the company as a significant player in the realms of healthcare and pharmaceuticals within China.

Products and Services

The product line and services offered by Changchun High-Tech Industry (Group) Co., Ltd. are diverse, catering to various aspects of the pharmaceutical industry:

• Genetic Engineering Pharmaceuticals: These encompass a range of products developed through genetic engineering techniques, focusing on innovation in pharmacology to offer effective treatment solutions.
• Biological Vaccines: The company is instrumental in the research, development, and manufacturing of vaccines. This includes preventive vaccines to combat various diseases, contributing to public health and safety.
• Modern Chinese Medicines: Integrating traditional Chinese medicine principles with contemporary pharmaceutical processes, these products aim to offer alternative and complementary therapeutic options.
• Antibody and Other Chemical Drugs: This category includes a variety of chemically synthesized drugs, including those developed using antibody technologies, to address a broad spectrum of medical conditions.
• Real Estate Development: Besides its core pharmaceutical operations, Changchun High-Tech engages in real estate development, demonstrating its diversified interests and capabilities beyond biopharmaceuticals.